12月17日金融一线消息，重庆市人民政府办公厅印发《重庆市推动"人工智能+"行动方案》，其中提 出，强化金融支撑。引导银行、保险等金融机构开发AI金融产品和服务。推动国有投资基金、社会资 本以市场化方式支持行业语料库建设、智能体与大模型开发等。培育一批耐心资本，鼓励市场化投资机 构为开展场景创新的企业提供融资支持。 责任编辑：王馨茹 责任编辑：王馨茹 12月17日金融一线消息，重庆市人民政府办公厅印发《重庆市推动"人工智能+"行动方案》，其中提 出，强化金融支撑。引导银行、保险等金融机构开发AI金融产品和服务。推动国有投资基金、社会资 本以市场化方式支持行业语料库建设、智能体与大模型开发等。培育一批耐心资本，鼓励市场化投资机 构为开展场景创新的企业提供融资支持。 ...

Sagicor Group Jamaica Ltd said on Tuesday it will merge with Sagicor Life Inc, unifying operations under a new holding company, Sagicor Group Caribbean, and in the process create a US$6.9-billion entity. The deal, struck with parent Sagicor Financial Company Ltd, will consolidate insurance, banking, and investment services across the Caribbean.“By merging our Caribbean operations, we are combining two institutions with deep roots and strong reputations across the Caribbean to form a regional champion with g ...

2025年12月16日，大理金融监管分局发布批复称，《新华人寿保险股份有限公司云南分公司关于新华人 寿保险股份有限公司大理中心支公司变更营业场所的请示》(新保云字〔2025〕98号)及相关说明解释材 料收悉。经审核，现批复如下： 二、新华人寿保险股份有限公司云南分公司应按照有关规定及时办理变更及许可证换领事宜。 一、同意新华人寿保险股份有限公司大理中心支公司将营业场所变更为：云南省大理白族自治州大理市 经济开发区满江街道大理创新工业园区漾濞路176号-2号(一楼)及176号-3号(三楼)。 ...

演示利率包含非保证利益部分，该部分收益不受合同刚性约束，最终实际收益需结合保险公司经营业绩、投资表现等因素动态调整，存在不确定性。 为何不同分红险产品的销售演示利率会存在差异？ 这与产品定价规则及监管政策要求直接相关。对于2025年以来推出的预定利率1.75%的新产品，监管明确限定销售演示利率上限，不超过3.9%和保险公 司近5年投资收益率平均值的较小者，避免过度演示误导消费者。 而市场上还有部分预定利率为1.50%的老产品，因出台时间早于最新监管要求，其销售演示利率可能超过4%，目前仍在合规范围内正常销售。 由于演示利率仅用于示例说明，无论其高低，均不构成对未来收益的承诺。保单持有人更应该关注分红险的客户收益率。 "13精"曾给出分红险客户收益率的计算公式： 正文： 选择分红险时，仅关注高销售演示利率是可行吗？ 答案显然是否定的。原因在于，销售演示利率高不等于实际收益率一定高！ 根据监管明确要求，分红险销售过程中必须清晰披露。 从上述公司来看，客户的实际收益最终取决于保险公司分红结算的投资收益率。 进一步，根据上述公式，我们对分红结算投资收益率与客户收益率的关系进行模拟。 在保险公司投资表现相同、分红结算投 ...

Core Insights - AIG has appointed Scott Leney as Regional President for Asia Pacific to enhance its market presence and drive growth in the region [1][2] - TD Cowen has raised AIG's price target from $86 to $90, reflecting confidence in the company's future performance under Leney's leadership [2][5] - AIG's current stock price is $84.67, with a market capitalization of approximately $45.69 billion [3][4][5] Company Performance - AIG's stock has experienced a slight decrease of 1.63 or -1.89%, trading within a range of $84.43 to $86.44 for the day [3] - Over the past year, AIG's stock has fluctuated between a high of $88.07 and a low of $69.24, indicating market volatility [3] - The trading volume on the NYSE for AIG is 3,125,449 shares, showing active investor interest [4] Market Position - AIG operates in over 80 countries and competes with major insurers like Allianz and Zurich Insurance Group, highlighting its significant role in the global insurance industry [1] - The decision by Cowen & Co. to maintain a "Hold" rating for AIG suggests a cautious approach, balancing growth potential with current market conditions [4]

Taiwan’s life insurers have cut their currency hedging to a record low, while boosting their buffer against foreign-exchange risks to give themselves a greater capacity to ride out any potential volatility https://t.co/Iq9Ab4l55j ...

[music] [music] Hello and welcome to Market Domination. [music] I'm Josh Lipton live from our New York headquarters. There's just now to go into the closing bell [music] and stocks are lower.Taking a look at the popular averages here. The Dow's down about 360 [music] points. The S&P 500, your broad gauge is down about 4/10 of a percent.The Nasdaq now [music] is basically flat. Let's welcome in here Jared Blickery joining us to break down the headlines. [clears throat] Jared, what are you seeing in the marke ...

Welcome back to Market on Close. I'm Sam Vardis live from the floor of the New York Stock Exchange. It's time now for overlooked stock.Shares of Lemonade are on the rise after Morgan Stanley upgraded shares this morning. So I'm joined by George Sillis to get us across this one, senior markets correspondent. So what is exactly the analyst saying which is behind uh this note today as to why the shares are rallying up at 9% right now, George.>> Yeah, I mean you look at Lemonade. In fact, in the last year, the ...

Core Viewpoint - Morgan Stanley downgraded Allstate to Equalweight from Overweight and lowered its price target to $215 due to a more competitive operating environment and a maturing investment thesis [1] Group 1: Investment Thesis - The previous investment case for Allstate, which was based on attractive valuation, improving growth, and margins exceeding consensus expectations, has largely played out [2] - Steady earnings from Allstate's homeowners insurance business are expected to provide some support in 2026, but rising competition necessitates a neutral stance [2] Group 2: Price Target and Valuation - Morgan Stanley reduced its price target to $215 per share, applying an estimated 8.9x price-to-earnings multiple to projected 2027 earnings per share of $24.07, reflecting a softening auto underwriting cycle [3] - The new target implies an estimated 1.6x price-to-book valuation, excluding AOCI, based on a projected 2027 operating return on equity of 18.5% [3]

The author has an honours degree in economics and politics with a focus on economic development. With 36 years of experience in executive management he has extensive knowledge of insurance/reinsurance, Global and Asia Pacific markets, climate change and ESG. He invests in his personal capacity.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Short position through short-selling of the stock, or purchase of put opt ...